Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Long-Term Follow-up of Patients with Aplastic Anemia Enrolled in Phase 2/3 Trials of Immunosuppressive Therapy Plus Romiplostim As a First-Line Treatment: Two-Year Interim Analysis

Blood (2024) 144 (Supplement 1): 1310.

https://doi.org/10.1182/blood-2024-193925

Published: 2024

Journal Articles

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Blood (2023) 142 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2023-181621

Published: 2023

Journal Articles

Impact of Conditioning Intensity and Regimen on Outcomes after Unrelated Cord Blood Transplantation for Patients with Myelodysplastic Syndrome

Machiko Fujioka, Hidehiro Itonaga, Yasushi Miyazaki, Yoshimitsu Shimomura, Naoyuki Uchida, Satoshi Takahashi, Makoto Onizuka, Yasunori Ueda, Yasufumi Uehara, Masatsugu Tanaka, Yoshiko Matsuhashi, Shigesaburo Miyakoshi, Haruyuki Tanaka, Toshiro Kawakita, Fumihiko Ishimaru, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Ken Ishiyama

Blood (2023) 142 (Supplement 1): 3536.

https://doi.org/10.1182/blood-2023-179157

Published: 2023

Journal Articles

Donor NK Cell Education By KIR3DL1 and HLA-B Associates with Reduced Relapse in Unrelated Bone Marrow Transplantation for Adult T-Cell Leukemia

Blood (2023) 142 (Supplement 1): 4982.

https://doi.org/10.1182/blood-2023-185474

Published: 2023

Journal Articles

Outcomes of Allogeneic Transplantation for Adult T-Cell Leukemia/Lymphoma in Adolescents and Young Adult (AYA) and Young Patients

Hidehiro Itonaga, Takuya Fukushima, Koji Kato, Nobuaki Nakano, Takeharu Kato, Takashi Tanaka, Tetsuya Eto, Yasuo Mori, Toshiro Kawakita, Naoyuki Uchida, Yasushi Sawayama, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Makoto Yoshimitsu, Shigeo Fuji

Blood (2023) 142 (Supplement 1): 1707.

https://doi.org/10.1182/blood-2023-173590

Published: 2023

Journal Articles

Impact of Early Anti-Cytomegalovirus Therapy on the Incidence of Chronic Graft-Versus-Host Disease

Kotaro Miyao, Makoto Murata, Tetsuya Nishida, Yukiyasu Ozawa, Naoyuki Uchida, Takahiro Fukuda, Noriko Doki, Tetsuya Eto, Toshiro Kawakita, Yasuo Mori, Satoru Takada, Hiroyuki Ohigashi, Masatsugu Tanaka, Yoshinobu Kanda, Ken-ichi Matsuoka, Fumihiko Ishimaru, Yoshiko Atsuta, Junya Kanda, Seitaro Terakura

Blood (2023) 142 (Supplement 1): 6993.

https://doi.org/10.1182/blood-2023-178592

Published: 2023

Journal Articles

The Comparison between BM and PBSC for the Patients with Pre-Transplant Pulmonary Dysfunction in HLA-Matched Allo-HCT: Subgroup Analysis Exploring the Impact Based on HCT Factors

Blood (2023) 142 (Supplement 1): 3609.

https://doi.org/10.1182/blood-2023-174431

Published: 2023

Journal Articles

Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age

Blood (2022) 140 (Supplement 1): 10598–10600.

https://doi.org/10.1182/blood-2022-158213

Published: 2022

Journal Articles

Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia

Blood (2021) 138 (Supplement 1): 1790.

https://doi.org/10.1182/blood-2021-147645

Published: 2021

Journal Articles

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Minoru Kanaya, Yasuo Morishima, Nobuyoshi Arima, Masahiro Hirayama, Souichi Shiratori, Noriko Doki, Yukiyasu Ozawa, Takahiro Fukuda, Masatsugu Tanaka, Masashi Sawa, Satoru Takada, Shuichi Ota, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima

Blood (2021) 138 (Supplement 1): 2919.

https://doi.org/10.1182/blood-2021-144669

Published: 2021

Journal Articles

Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Shuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, Yuho Najima, Takeshi Kobayashi, Yukiyasu Ozawa, Yoshinobu Kanda, Shinichi Kako, Toshiro Kawakita, Ken-Ichi Matsuoka, Yumiko Maruyama, Shuichi Ota, Hideyuki Nakazawa, Kazunori Imada, Takafumi Kimura, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Ken Ishiyama

Blood (2021) 138 (Supplement 1): 3692.

https://doi.org/10.1182/blood-2021-144689

Published: 2021

Journal Articles

Matched HLA Haplotype Contributes to Reduce Sever Acute GVHD with Conserving GVL Effect in HLA-Mismatched Cord Blood Transplantation,

Satoshi Takahashi, M.D., Ph.D., Jun Ooi, MD, Seiko Kato, M.D., Toshiro Kawakita, M.D., Arinobu Tojo, MD, PhD, Yasuhiro Ebihara, MD, PhD, Shinji Mochizuki, MD, PhD, Shohei Yamamoto, MD, PhD, Kohichiro Tsuji, MD, PhD, Takuhiro Yamaguchi, Ph.D., Satoko Morishima, MD., Ph.D., Yasuo Morishima, MD, PhD, Shigetaka Asano, MD

Blood (2011) 118 (21): 4140.

https://doi.org/10.1182/blood.V118.21.4140.4140

Published: 2011

Journal Articles

The Impact of HLA Haplotype Matching for Mismatched Cord Blood Transplantation.

Satoshi Takahashi, M.D., Jun Ooi, M.D., Nobuhiro Tsukada, M.D., Seiko Kato, M.D., Aki Sato, M.D., Toshiro Kawakita, M.D., Yasuyuki Nagata, M.D., Maki Monna-Ooiwa, Arinobu Tojo, MD, Takuhiro Yamaguchi, Ph.D., Satoko Morishima, M.D., Yasuo Morishima, M.D., Shigetaka Asano, M.D.

Blood (2009) 114 (22): 1206.

https://doi.org/10.1182/blood.V114.22.1206.1206

Published: 2009

Journal Articles

Prognostic Factors Associated with Outcomes of RIC and MAC Hematopoietic Stem Cell Transplantation: An Indication for the Selection of Conditioning

Tetsuyuki Kiyokawa, Shoichi Nagakura, Michihiro Hidaka, Takahiro Yano, MD, Kazutaka Sunami, MD, PhD, Seiichi Okamura, Naokuni Uike, Motohiro Hamaguchi, Takahiro Matsui, Keizo Horibe, MD, Kensaku Sato, Toshiro Kawakita, Fumio Kawano

Blood (2008) 112 (11): 4402.

https://doi.org/10.1182/blood.V112.11.4402.4402

Published: 2008

Journal Articles

Risk Factors Associated with VOD with RIC and MAC Hematopoietic Stem Cell Transplant and the Early Estimation of VOD

Shoichi Nagakura, Tetsuyuki Kiyokawa, Michihiro Hidaka, Takahiro Yano, MD, Kazutaka Sunami, MD, PhD, Seiichi Okamura, Naokuni Uike, Motohiro Hamaguchi, Takahiro Matsui, Keizo Horibe, MD, Kensaku Sato, Toshiro Kawakita, Fumio Kawano

Blood (2008) 112 (11): 4315.

https://doi.org/10.1182/blood.V112.11.4315.4315

Published: 2008

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients.

Shigeki Takemoto, MD, Michihiro Hidaka, MD, Shoichi Nagakura, MD, Tatsunori Sakai, MD, Takahiro Matsui, MD, Toshiro Kawakita, MD, Yoshiko Inoue, MD, Atsuko Tsukamoto, MD, Tetsuyuki Kiyokawa, MD, Fumio Kawano, MD

Blood (2007) 110 (11): 5037.

https://doi.org/10.1182/blood.V110.11.5037.5037

Published: 2007

Journal Articles

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

Tomoko Nanri, MD, PhD, Eisaku Iwanaga, MD, Naofumi Matsuno, MD, PhD, Toshiro Kawakita, MD, Hitoshi Suzushima, MD, PhD, Fumio Kawano, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2007) 110 (11): 3492.

https://doi.org/10.1182/blood.V110.11.3492.3492

Published: 2007

Journal Articles

Acute Promyelocytic Leukemia Harboring STAT5b-RAR α Fusion Gene and G596V Mutation in the Stat5b SH2 Domain of the Fusion Gene.

Eisaku Iwanaga, Miki Nakamura, Tomoko Nanri, Toshiro Kawakita, Naofumi Matsuno, Koyu Hoshino, Kentaro Horikawa, Hiroaki Mitsuya, Norio Asou

Blood (2007) 110 (11): 4227.

https://doi.org/10.1182/blood.V110.11.4227.4227

Published: 2007

Journal Articles

A Pedigree Harboring a Germ-Line N-Terminal C/EBPα Mutation and Development of Acute Myeloblastic Leukemia with a Somatic C-Terminal C/EBPα Mutation.

Tomoko Nanri, MD, Naokuni Uike, MD, Toshiro Kawakita, MD, Eisaku Iwanaga, MD, Koyu Hoshino, MD, Hiroaki Mitsuya, MD, Norio Asou, MD

Blood (2006) 108 (11): 1916.

https://doi.org/10.1182/blood.V108.11.1916.1916

Published: 2006

Journal Articles

Familial Acute Myeloblastic Leukemia with a Dominant Negative Mutation in the CEBPA Gene.

Tomoko Nanri, MD, Toshiro Kawakita, MD, Koyu Hoshino, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD, Naokuni Uike, MD

Blood (2005) 106 (11): 4564.

https://doi.org/10.1182/blood.V106.11.4564.4564

Published: 2005

NARROW

Long-Term Follow-up of Patients with Aplastic Anemia Enrolled in Phase 2/3 Trials of Immunosuppressive Therapy Plus Romiplostim As a First-Line Treatment: Two-Year Interim Analysis

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Impact of Conditioning Intensity and Regimen on Outcomes after Unrelated Cord Blood Transplantation for Patients with Myelodysplastic Syndrome

Donor NK Cell Education By KIR3DL1 and HLA-B Associates with Reduced Relapse in Unrelated Bone Marrow Transplantation for Adult T-Cell Leukemia

Outcomes of Allogeneic Transplantation for Adult T-Cell Leukemia/Lymphoma in Adolescents and Young Adult (AYA) and Young Patients

Impact of Early Anti-Cytomegalovirus Therapy on the Incidence of Chronic Graft-Versus-Host Disease

The Comparison between BM and PBSC for the Patients with Pre-Transplant Pulmonary Dysfunction in HLA-Matched Allo-HCT: Subgroup Analysis Exploring the Impact Based on HCT Factors

Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age

Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Matched HLA Haplotype Contributes to Reduce Sever Acute GVHD with Conserving GVL Effect in HLA-Mismatched Cord Blood Transplantation,

The Impact of HLA Haplotype Matching for Mismatched Cord Blood Transplantation.

Prognostic Factors Associated with Outcomes of RIC and MAC Hematopoietic Stem Cell Transplantation: An Indication for the Selection of Conditioning

Risk Factors Associated with VOD with RIC and MAC Hematopoietic Stem Cell Transplant and the Early Estimation of VOD

Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients.

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

Acute Promyelocytic Leukemia Harboring STAT5b-RAR α Fusion Gene and G596V Mutation in the Stat5b SH2 Domain of the Fusion Gene.

A Pedigree Harboring a Germ-Line N-Terminal C/EBPα Mutation and Development of Acute Myeloblastic Leukemia with a Somatic C-Terminal C/EBPα Mutation.

Familial Acute Myeloblastic Leukemia with a Dominant Negative Mutation in the CEBPA Gene.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only